0001209191-23-033341.txt : 20230601 0001209191-23-033341.hdr.sgml : 20230601 20230601162151 ACCESSION NUMBER: 0001209191-23-033341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230530 FILED AS OF DATE: 20230601 DATE AS OF CHANGE: 20230601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Batycky Alka CENTRAL INDEX KEY: 0001978041 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39971 FILM NUMBER: 23984996 MAIL ADDRESS: STREET 1: C/O LANDOS BIOPHARMA, INC. STREET 2: P.O. BOX 11239 CITY: BLACKSBURG STATE: VA ZIP: 24062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Landos Biopharma, Inc. CENTRAL INDEX KEY: 0001785345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 815085535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 KRAFT DRIVE, SUITE 216 CITY: BLACKSBURG STATE: VA ZIP: 24060 BUSINESS PHONE: 540-818-2844 MAIL ADDRESS: STREET 1: 1800 KRAFT DRIVE, SUITE 216 CITY: BLACKSBURG STATE: VA ZIP: 24060 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-30 0 0001785345 Landos Biopharma, Inc. LABP 0001978041 Batycky Alka C/O LANDOS BIOPHARMA, INC. PO BOX 11239 BLACKSBURG VA 24062 1 0 0 0 0 Stock Option (right to buy) 3.05 2023-05-30 4 A 0 3600 0.00 A 2033-05-29 Common Stock 3600 3600 D The shares of common stock underlying the option will vest and become exercisable in 36 equal monthly installments beginning on May 30, 2023, subject to the Reporting Person's continuous service with the Issuer on each such date. /s/ Gregory Oakes, attorney-in-fact 2023-06-01